Floatz logo

Ifosfamide

Precancerous/Nonmalignant Condition

Cancer Treatment Centers of AmericaPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Precancerous/Nonmalignant Condition cohort.

Asset / SponsorPhaseRating
Darbepoetin Alfa
Mayo Clinic
Phase 3BB
Epoetin Alfa
Mayo Clinic
Phase 3BB
Cyclophosphamide
Institut Paoli-Calmettes
Phase 2BB
CYCLOSPORIN A
Institut Paoli-Calmettes
Phase 2BB
Fludarabine
Institut Paoli-Calmettes
Phase 2BB

View all 50 →

Same molecule, other indications

Ifosfamide is also rated in:

angioimmunoblastic T-cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
primary mediastinal large B-cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →